Rinsing with alcohol-free or alcoholbased Chlorhexidine solutions after periodontal surgery. A double-blind, randomized, crossover,pilotstudy

Department of Periodontology, The Institute for Postgraduate Dental Education, Jönköping, Sweden.
Swedish dental journal (Impact Factor: 0.73). 08/2012; 36(2):91-9.
Source: PubMed


The aim of this randomized, double-blind, cross-over pilot study was to evaluate the effect on plaque formation and patient experience of rinsing after periodontal surgery using chlorhexidine solution with or without alcohol. Twenty patients refrained from tooth brushing after surgery and used two mouth rinses.Ten patients used alcohol-based (AB) 0.1% and another ten used alcohol-free (AF) 0.12% chlorhexidine (CHX). Sutures were removed after 2 weeks and teeth were cleaned; thereafter, the two groups shifted solution. Plaque at operated teeth was recorded at 2 and 4 weeks (Quigley-Hein Index). Patient experience was assessed with a visual analogue scale (0-10). Mean (SD) plaque indices at 2 and 4 weeks were 1.0 (0.8) and 1.1 (1.0) for AB CHX and 1.1 (0.7) and 0.8 (0.7) for AF CHX, respectively (no significant differences between solutions). At 2 weeks, between-group differences in taste experience of the solutions differed non-significantly: 6.1 (2.8) for AB and 6.0 (2.3) for AF. At 4 weeks, values were 4.6 (2.5) for AB and 6.9 (3.3) for AF-patients tended to prefer AF (p = 0.050). Taste change over the study period was equal for both groups: -37 (3.3) for AB and 3.4 (2.3) for AF at 2 weeks and slightly higher at 4 weeks 4.9 (2.8) and 4.5 (2.5) for AB and AF, respectively. Smarting was low in both groups: 2.2 (3.2) and 1.3 (2.2) for AB and 1.0 (1.5) and 1.9 (2.0) for AF at 2 and 4 weeks, respectively. To conclude, alcohol-free and alcohol-based chlorhexidine showed the same plaque inhibitory effect in periodontal patients after periodontal surgery. Both rinses were well tolerated by the patients.

1 Follower
42 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective To evaluate the periodontal status of HIV seropositive patients and to find out if any correlation exists between the severity of periodontal disease and the CD4 cell count in HIV patients.Methods One hundred and thirty patients attending the Viral Diseases OPD, Calcutta School of Tropical Medicine, Kolkata were examined. They were grouped according to the CD4 cell count as Group A – Subjects with CD4 Cell count < 200/μL and Group B – Subjects with CD4 Cell count≥200/μL. Their community periodontal index of treatment needs (CPITN) score were recorded.ResultsIt was found that most of the patients in each group were having score ‘2’ (i.e. presence of supra or subgingival calculus), as their highest score. A statistically significant association was found between immune status as depicted by CD4 cell count and periodontal status as shown by highest CPITN score in the present study.Conclusions The present study confirms the effect of immunosuppression on periodontal diseases in HIV infected patients.
    Asian Pacific Journal of Tropical Disease 12/2012; 2(6):470–474. DOI:10.1016/S2222-1808(12)60102-9
  • [Show abstract] [Hide abstract]
    ABSTRACT: Antiseptika und Antiinfektiva werden in der Zahnmedizin prophylaktisch abhängig vom Risikoprofil des Patienten und vom geplanten chirurgischen Eingriff routinemäßig eingesetzt. Zu den enoral angewendeten Antiseptika zur Reduktion der lokalen Keimzahl zählen Spüllösungen wie Chlorhexidin (0,03–0,2%, z. B. Paroex 0,12%), Polyvidon-Iod (z. B. Betaisodona-Mund-Antiseptikum) oder Octenidin (z. B. Octenidol-Mundspüllösung). Neben Antibiotika zählen auch Antimykotika, Antiparasitika und Virustatika zu den Antiinfektiva, wobei der Einsatz von Antibiotika in der Zahnmedizin im Vordergrund steht. Während einer Radiatio, Chemotherapie oder Stammzelltransplantation können auch Amtimykotika oder Virustatika zum Einsatz kommen. In diesem Artikel wird hauptsächlich auf die prophylaktische Einnahme von systemischen Antibiotika zur Vermeidung einer Gingivitis, einer Bakteriämie und von Wundheilungsstörungen bei chirurgischen Eingriffen, aber auch vor professionellen Zahnreinigungen oder einer Parodontitistherapie eingegangen.
    02/2013; 7(1). DOI:10.1007/s11838-012-0164-5